Skip to main content
. 2014 Nov 5;10(1):21–28. doi: 10.2215/CJN.04750514

Table 2.

General characteristics according RRT during ICU stay before and after propensity-scoring matching

Characteristic Before Matching After Matching
No RRT (n=17,878) RRT 
(n=532) P No RRT 
(n=502) RRT 
(n=502) P
Age (yr) 63.9±17.6 64.1±15.5 0.73 64.8±17.2 64.5±15.2 0.87
Men 10,116 (56.6) 318 (59.8) 0.21 302 (60.2) 299 (59.6) 0.98
Hypertension 6032 (33.7) 71 (13.3) <0.001 128 (25.5) 66 (13.1) <0.001
Diabetes mellitus 3473 (19.4) 114 (21.4) 0.25 107 (21.3) 107 (21.3) 1.00
Congestive heart failure 3405 (19.0) 217 (40.8) <0.001 197 (39.2) 203 (40.4) 0.70
COPD 3018 (16.9) 78 (14.7) 0.18 86 (17.1) 78 (15.5) 0.49
Liver disease 830 (4.6) 70 (13.2) <0.001 64 (12.7) 64 (12.7) 1.00
Solid tumors 2737 (15.3) 43 (8.1) <0.001 44 (8.8) 43 (8.6) 0.91
Lymphoma 280 (1.6) 10 (1.9) 0.57 12 (2.4) 10 (2.0) 0.67
Metastatic cancer 813 (4.5) 10 (1.9) 0.003 8 (1.6) 10 (2.0) 0.63
Sepsis 1868 (10.4) 219 (41.9) <0.001 188 (37.5) 194 (38.6) 0.70
SAPS on ICU admission 14 (10–17) 18 (13–22) <0.001 17 (12–21) 18 (13–21) 0.48
SOFA on ICU admission 5 (2–8) 10 (7–14) <0.001 10 (6–13) 10 (6–14) 0.62
Hyperkalemia 1399 (7.8) 205 (38.5) <0.001 164 (32.7) 190 (37.8) 0.22
Azotemia (BUN>60 mg/dl) 1456 (8.1) 319 (60.0) <0.001 289 (57.6) 290 (57.8) 0.95
Cumulative fluid balance > 5% body wt 7035 (53.5) 324 (76.8) <0.001 312 (76.1) 299 (75.5) 0.84
Hyponatremia 4930 (27.6) 322 (60.5) <0.001 273 (54.4) 289 (57.6) 0.50
Urine output <400 ml/24 h 4150 (23.7) 414 (84.8) <0.001 360 (71.7) 375 (74.7) 0.95
Metabolic acidosis 12,352 (69.1) 476 (89.5) <0.001 436 (89.2) 446 (88.8) 0.38
Alkali therapy 955 (5.3) 182 (34.2) <0.001 161 (32.1) 158 (31.5) 0.84
Diuretic use during ICU stay 7463 (41.7) 259 (48.7) 0.001 228 (45.4) 243 (48.4) 0.38

Data are expressed as the mean±SD, n (%), or median (interquartile range). Alkali and diuretic therapy were considered only if administered before RRT.